BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis
USA - NASDAQ:BTSG - US10950A1060 - Common Stock
33.49 USD
+0.44 (+1.33%)
34.27 USD
+0.78 (+2.33%)
BTSG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. BTSG has only an average score on both its financial health and profitability. BTSG is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
BTSG had positive earnings in the past year.
In the past year BTSG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BTSG reported negative net income in multiple years.
BTSG had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of BTSG (2.14%) is comparable to the rest of the industry.
The Return On Equity of BTSG (7.13%) is better than 66.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.68%, BTSG is in line with its industry, outperforming 54.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BTSG is significantly below the industry average of 9.40%.
The 3 year average ROIC (3.45%) for BTSG is below the current ROIC(4.68%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROIC | 4.68% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
1.3 Margins
With a Profit Margin value of 1.04%, BTSG perfoms like the industry average, outperforming 56.00% of the companies in the same industry.
BTSG's Operating Margin of 2.15% is in line compared to the rest of the industry. BTSG outperforms 49.00% of its industry peers.
In the last couple of years the Operating Margin of BTSG has grown nicely.
The Gross Margin of BTSG (12.30%) is worse than 70.00% of its industry peers.
In the last couple of years the Gross Margin of BTSG has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% |
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
2. Health
2.1 Basic Checks
BTSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BTSG has more shares outstanding than it did 1 year ago.
BTSG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BTSG has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.25 indicates that BTSG is not in any danger for bankruptcy at the moment.
BTSG's Altman-Z score of 3.25 is fine compared to the rest of the industry. BTSG outperforms 66.00% of its industry peers.
The Debt to FCF ratio of BTSG is 9.17, which is on the high side as it means it would take BTSG, 9.17 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 9.17, BTSG perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
A Debt/Equity ratio of 1.36 is on the high side and indicates that BTSG has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.36, BTSG is doing worse than 66.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Altman-Z | 3.25 |
ROIC/WACC0.5
WACC9.29%
2.3 Liquidity
A Current Ratio of 1.79 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG's Current ratio of 1.79 is fine compared to the rest of the industry. BTSG outperforms 68.00% of its industry peers.
A Quick Ratio of 1.38 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG has a Quick ratio of 1.38. This is comparable to the rest of the industry: BTSG outperforms 55.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 117.02% over the past year.
Looking at the last year, BTSG shows a quite strong growth in Revenue. The Revenue has grown by 17.23% in the last year.
Measured over the past years, BTSG shows a very strong growth in Revenue. The Revenue has been growing by 20.01% on average per year.
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
3.2 Future
The Earnings Per Share is expected to grow by 38.52% on average over the next years. This is a very strong growth
BTSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.46% yearly.
EPS Next Y85.44%
EPS Next 2Y54.69%
EPS Next 3Y43.24%
EPS Next 5Y38.52%
Revenue Next Year12.92%
Revenue Next 2Y13.3%
Revenue Next 3Y13.01%
Revenue Next 5Y12.46%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 32.83, the valuation of BTSG can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BTSG is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.51, BTSG is valued a bit more expensive.
With a Price/Forward Earnings ratio of 25.45, BTSG can be considered very expensive at the moment.
BTSG's Price/Forward Earnings ratio is in line with the industry average.
BTSG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.53.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.83 | ||
| Fwd PE | 25.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BTSG is on the same level as its industry peers.
63.00% of the companies in the same industry are more expensive than BTSG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.49 | ||
| EV/EBITDA | 18.49 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BTSG's earnings are expected to grow with 43.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y54.69%
EPS Next 3Y43.24%
5. Dividend
5.1 Amount
No dividends for BTSG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
33.49
+0.44 (+1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners70.16%
Inst Owner Change0.11%
Ins Owners2.57%
Ins Owner Change-4.52%
Market Cap5.93B
Revenue(TTM)12.41B
Net Income(TTM)129.59M
Analysts84.21
Price Target33.11 (-1.13%)
Short Float %17.1%
Short Ratio4.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.34%
PT rev (3m)15.49%
EPS NQ rev (1m)9.76%
EPS NQ rev (3m)24.14%
EPS NY rev (1m)8.14%
EPS NY rev (3m)19.16%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.83 | ||
| Fwd PE | 25.45 | ||
| P/S | 0.48 | ||
| P/FCF | 21.49 | ||
| P/OCF | 16.99 | ||
| P/B | 3.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.49 |
EPS(TTM)1.02
EY3.05%
EPS(NY)1.32
Fwd EY3.93%
FCF(TTM)1.56
FCFY4.65%
OCF(TTM)1.97
OCFY5.89%
SpS70.07
BVpS10.27
TBVpS-6.06
PEG (NY)0.38
PEG (5Y)N/A
Graham Number15.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROCE | 5.92% | ||
| ROIC | 4.68% | ||
| ROICexc | 4.83% | ||
| ROICexgc | 14.34% | ||
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% | ||
| FCFM | 2.22% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Debt/EBITDA | 5.55 | ||
| Cap/Depr | 40.71% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 1.44 | ||
| Cash Conversion | 78.31% | ||
| Profit Quality | 213.06% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.25 |
F-Score7
WACC9.29%
ROIC/WACC0.5
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y85.44%
EPS Next 2Y54.69%
EPS Next 3Y43.24%
EPS Next 5Y38.52%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
Revenue Next Year12.92%
Revenue Next 2Y13.3%
Revenue Next 3Y13.01%
Revenue Next 5Y12.46%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year60.02%
EBIT Next 3Y26.18%
EBIT Next 5Y28%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%
BRIGHTSPRING HEALTH SERVICES / BTSG FAQ
Can you provide the ChartMill fundamental rating for BRIGHTSPRING HEALTH SERVICES?
ChartMill assigns a fundamental rating of 4 / 10 to BTSG.
What is the valuation status for BTSG stock?
ChartMill assigns a valuation rating of 4 / 10 to BRIGHTSPRING HEALTH SERVICES (BTSG). This can be considered as Fairly Valued.
How profitable is BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
BRIGHTSPRING HEALTH SERVICES (BTSG) has a profitability rating of 4 / 10.
What is the expected EPS growth for BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
The Earnings per Share (EPS) of BRIGHTSPRING HEALTH SERVICES (BTSG) is expected to grow by 85.44% in the next year.